(Q48018791)

7 February 2018

title

Resistance to artemisinin-based combination therapy (English)

1 reference

7 February 2018

0 references

1

Joel G Breman

1 reference

7 February 2018

publication date

30 August 2012

1 reference

7 February 2018

Lancet Infectious Diseases

published in

1 reference

7 February 2018

volume

12

1 reference

7 February 2018

issue

11

1 reference

7 February 2018

page(s)

820-822

1 reference

7 February 2018

Artemisinin Resistance in Plasmodium falciparum Malaria

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970226-8

7 January 2021

Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970226-8

7 January 2021

A major genome region underlying artemisinin resistance in malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970226-8

7 January 2021

Prolonged selection of pfmdr1 polymorphisms after treatment of falciparum malaria with artemether-lumefantrine in Uganda

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970226-8

7 January 2021

Dynamics of Plasmodium falciparum selection after artemether-lumefantrine treatment in Africa

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970226-8

7 January 2021

Artemisinin-resistant malaria: research challenges, opportunities, and public health implications

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970226-8

7 January 2021

Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2812%2970226-8

7 January 2021

10.1016/S1473-3099(12)70226-8

Identifiers

DOI

1 reference

7 February 2018

1 reference

7 February 2018